New $3.26 million grant launches Undiagnosed Diseases Network site in New York

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d’Oncologia (ICO) and

February 5, 2024

Amid another rise in cases, Covid’s new normal has set in

Among people who are still paying attention to Covid-19, there’s been a recent surge — not just in viral activity but in the concern once

September 10, 2023

Study Finds 3 Variables Predicting the Intensity of a Psychedelic Experience | Psychedelic Spotlight

What variables, if any, can predict the intensity of a psychedelic mystical experience? Perhaps a better question to ask is: why would identifying these

October 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.